Literature DB >> 102705

A method for the preparation of protein-protein conjugates of predetermined composition.

E S Rector, R J Schwenk, K S Tse, A H Sehon.   

Abstract

A novel procedure for the synthesis of well-defined protein-protein conjugates is described using ovalbumin (OA) and IgG as test proteins. This procedure involves the highly selective and rapid reaction of alkyl halide and sulfhydryl groups, which have been grafted, respectively, onto the proteins to be conjugated. Accordingly, iodoacetylated IgG, (ICH2CO)nIgG, was prepared by the reaction of the epsilon-amino groups of IgG with the N-hydroxysuccinimide ester of iodoacetic acid (NHIA), the degree of iodoacetylation (n) being proportional to the concentration of NHIA. OA was reacted with S-acetylmercaptosuccinic anhydride (SAMSA) under conditions yielding, on the average, a monosubstituted derivative. Following removal of the protective S-acetyl group, the resulting -SH derivative of OA was reacted with (ICH2CO)nIgG. The OAx-IgG conjugates so produced were characterized by gel filtration, specific radioactivity (using tritiated OA) and immunodiffusion. It was found that the average number of OA molecules coupled per IgG molecule could be controlled by varying the degree of iodoacetylation of IgG.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 102705     DOI: 10.1016/0022-1759(78)90135-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Development of sulfhydryl-reactive silica for protein immobilization in high-performance affinity chromatography.

Authors:  Rangan Mallik; Chunling Wa; David S Hage
Journal:  Anal Chem       Date:  2007-02-15       Impact factor: 6.986

2.  Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3.

Authors:  K Kaushansky; S G Shoemaker; V C Broudy; N L Lin; J V Matous; E M Alderman; J D Aghajanian; P J Szklut; R E VanDyke; M K Pearce
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

3.  In situ 125I-labelling of endosome proteins with lactoperoxidase conjugates.

Authors:  C Watts
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

4.  Solid-phase synthesis provides a modular, lysine-based platform for fluorescent discrimination of nitroxyl and biological thiols.

Authors:  Andrei Loas; Robert J Radford; Alexandria Deliz Liang; Stephen J Lippard
Journal:  Chem Sci       Date:  2015-05-19       Impact factor: 9.825

5.  Comparative pharmacokinetic properties of murine monoclonal antibody A7 modified with neocarzinostatin, dextran and polyethylene glycol.

Authors:  K Takashina; K Kitamura; T Yamaguchi; A Noguchi; A Noguchi; H Tsurumi; T Takahashi
Journal:  Jpn J Cancer Res       Date:  1991-10

6.  The Impact of Sustained Immunization Regimens on the Antibody Response to Oligomannose Glycans.

Authors:  Dung N Nguyen; Richard L Redman; Satoru Horiya; Jennifer K Bailey; Bokai Xu; Robyn L Stanfield; J Sebastian Temme; Celia C LaBranche; Shiyu Wang; Avital A Rodal; David C Montefiori; Ian A Wilson; Isaac J Krauss
Journal:  ACS Chem Biol       Date:  2020-03-09       Impact factor: 5.100

7.  The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitro.

Authors:  F Searle; C Bier; R G Buckley; S Newman; R B Pedley; K D Bagshawe; R G Melton; S M Alwan; R F Sherwood
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

8.  Conjugation of monoclonal antibodies to a synthetic peptide substrate for protein kinase: a method for labelling antibodies with 32P.

Authors:  B M Foxwell; H A Band; J Long; W A Jeffery; D Snook; P E Thorpe; G Watson; P J Parker; A A Epenetos; A M Creighton
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.